Correlation Between Neuropace and Heart Test
Can any of the company-specific risk be diversified away by investing in both Neuropace and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Heart Test Laboratories, you can compare the effects of market volatilities on Neuropace and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Heart Test.
Diversification Opportunities for Neuropace and Heart Test
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neuropace and Heart is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Neuropace i.e., Neuropace and Heart Test go up and down completely randomly.
Pair Corralation between Neuropace and Heart Test
Given the investment horizon of 90 days Neuropace is expected to generate 0.47 times more return on investment than Heart Test. However, Neuropace is 2.15 times less risky than Heart Test. It trades about 0.09 of its potential returns per unit of risk. Heart Test Laboratories is currently generating about -0.02 per unit of risk. If you would invest 158.00 in Neuropace on August 24, 2024 and sell it today you would earn a total of 742.00 from holding Neuropace or generate 469.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuropace vs. Heart Test Laboratories
Performance |
| Timeline |
| Neuropace |
| Heart Test Laboratories |
Neuropace and Heart Test Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and Heart Test
The main advantage of trading using opposite Neuropace and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
| Heart Test vs. Neuropace | Heart Test vs. Inogen Inc | Heart Test vs. SurModics | Heart Test vs. Pulmonx Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |